[1] |
Alkrekshi A, Mustafa M, Abdul⁃Al H, et al. Recurrent cutaneous squamous cell carcinoma with direct invasion of the pleura: a case report[J]. Cureus, 2019,11(7):e5115. doi: 10.7759/cureus. 5115.
|
[2] |
Venables ZC, Nijsten T, Wong KF, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013⁃15: a cohort study[J]. Br J Dermatol, 2019,181(3):474⁃482. doi: 10.1111/bjd.17873.
|
[3] |
Taylor SL, Renshaw BR, Garka KE, et al. Genomic organization of the interleukin⁃1 locus[J]. Genomics, 2002,79(5):726⁃733. doi: 10.1006/geno.2002.6752.
|
[4] |
Kivisaari A, Kähäri VM. Squamous cell carcinoma of the skin: Emerging need for novel biomarkers[J]. World J Clin Oncol, 2013,4(4):85⁃90. doi: 10.5306/wjco.v4.i4.85.
|
[5] |
Vigliani MB, Cunha CB. Multiple recurrent abscesses in a patient with undiagnosed IL⁃12 deficiency and infection by Burkholderia gladioli[J]. IDCases, 2018,12:80⁃83. doi: 10.1016/j.idcr.2018.03.018.
|
[6] |
Ratushny V, Gober MD, Hick R, et al. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma[J]. J Clin Invest, 2012,122(2):464⁃472. doi: 10.1172/JCI57415.
|
[7] |
Amiraraghi N, Scott RA, Balaji N, et al. Human papillomavirus 16 and p16 positive nasal cutaneous squamous cell carcinoma in immunocompetent men in their twenties[J]. J Laryngol Otol, 2019,133(4):348⁃352. doi: 10.1017/S0022215119000641.
|
[8] |
Fujimoto M, Matsuzaki I, Takahashi Y, et al. High⁃risk human papillomavirus E6/E7 mRNA is rarely detected in nonanogenital cutaneous squamous cell carcinoma: an RNA in situ hybridization⁃based tissue microarray study[J]. Am J Dermatopathol, 2019,41(3):205⁃210. doi: 10.1097/DAD.000000 0000001289.
|
[9] |
Rollison DE, Pawlita M, Giuliano AR, et al. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers[J]. Int J Cancer, 2008,123(10):2337⁃2342. doi: 10.1002/ijc. 23795.
|
[10] |
Chen ML, Wang SH, Wei JC, et al. The impact of human papillomavirus infection on skin cancer: a population⁃based cohort study[J]. Oncologist, 2021,26(3):e473⁃e483. doi: 10. 1002/onco.13593.
|
[11] |
Tommasino M. The biology of beta human papillomaviruses[J]. Virus Res, 2017,231:128⁃138. doi: 10.1016/j.virusres.2016.11. 013.
|
[12] |
Meyers JM, Munger K. The viral etiology of skin cancer[J]. J Invest Dermatol, 2014,134(e1):E29⁃E32. doi: 10.1038/skinbio. 2014.6.
|
[13] |
Viarisio D, Decker KM, Aengeneyndt B, et al. Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis[J]. J Gen Virol, 2013,94(Pt 4):749⁃752. doi: 10.1099/vir.0.048991⁃0.
|
[14] |
Hasche D, Stephan S, Braspenning⁃Wesch I, et al. The interplay of UV and cutaneous papillomavirus infection in skin cancer development[J]. PLoS Pathog, 2017,13(11):e1006723. doi: 10.1371/journal.ppat.1006723.
|
[15] |
Chakraborty B, Mukhopadhyay D, Roychowdhury A, et al. Differential Wnt⁃β⁃catenin pathway activation in HPV positive and negative oral epithelium is transmitted during head and neck tumorigenesis: clinical implications[J]. Med Microbiol Immunol, 2021,210(1):49⁃63. doi: 10.1007/s00430⁃020⁃00697⁃9.
|
[16] |
Sitte M, Menck K, Wachter A, et al. Reconstruction of different modes of WNT dependent protein networks from time series protein quantification[J]. Stud Health Technol Inform, 2019,267:175⁃180. doi: 10.3233/SHTI190823.
|
[17] |
Su Z, Song J, Wang Z, et al. Tumor promoter TPA activates Wnt/β⁃catenin signaling in a casein kinase 1⁃dependent manner[J]. Proc Natl Acad Sci U S A, 2018,115(32):E7522⁃E7531. doi: 10.1073/pnas.1802422115.
|
[18] |
Li C, Liang Y, Cao J, et al. The delivery of a Wnt pathway inhibitor toward cscs requires stable liposome encapsulation and delayed drug release in tumor tissues[J]. Mol Ther, 2019,27(9):1558⁃1567. doi: 10.1016/j.ymthe.2019.06.013.
|
[19] |
El⁃Sahli S, Xie Y, Wang L, et al. Wnt signaling in cancer metabolism and immunity[J]. Cancers (Basel), 2019,11(7):904. doi: 10.3390/cancers11070904.
|
[20] |
Steinhart Z, Angers S. Wnt signaling in development and tissue homeostasis[J]. Development, 2018,145(11):dev146589. doi: 10.1242/dev.146589.
|
[21] |
Zimmerli D, Cecconi V, Valenta T, et al. WNT ligands control initiation and progression of human papillomavirus⁃driven squamous cell carcinoma[J]. Oncogene, 2018,37(27):3753⁃3762. doi: 10.1038/s41388⁃018⁃0244⁃x.
|
[22] |
Zimmerli D, Borrelli C, Jauregi⁃Miguel A, et al. TBX3 acts as tissue⁃specific component of the Wnt/β⁃catenin transcriptional complex[J]. Elife, 2020,9:e58123. doi: 10.7554/eLife.58123.
|
[23] |
Lu X, Jiang L, Zhang L, et al. Immune signature⁃based subtypes of cervical squamous cell carcinoma tightly associated with human papillomavirus type 16 expression, molecular features, and clinical outcome[J]. Neoplasia, 2019,21(6):591⁃601. doi: 10.1016/j.neo.2019.04.003.
|
[24] |
Viarisio D, Müller⁃Decker K, Accardi R, et al. Beta HPV38 oncoproteins act with a hit⁃and⁃run mechanism in ultraviolet radiation⁃induced skin carcinogenesis in mice[J]. PLoS Pathog, 2018,14(1):e1006783. doi: 10.1371/journal.ppat.1006783.
|
[25] |
Pacini L, Ceraolo MG, Venuti A, et al. UV radiation activates Toll⁃like receptor 9 expression in primary human keratinocytes, an event inhibited by human papillomavirus 38 E6 and E7 oncoproteins[J]. J Virol, 2017,91(19):e01123⁃17. doi: 10.1128/JVI.01123⁃17.
|
[26] |
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens⁃⁃Part B: biological agents[J]. Lancet Oncol, 2009,10(4):321⁃322. doi: 10.1016/s1470⁃2045(09)70096⁃8.
|